🇺🇸 FDA
Pipeline program

LCAR-HL30 cells

LB2203-0001

Phase 1 mab active

Quick answer

LCAR-HL30 cells for Hodgkin's Lymphoma is a Phase 1 program (mab) at Legend Biotech Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Legend Biotech Corp
Indication
Hodgkin's Lymphoma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials